T1	p 38 74	people at high cardiovascular risk :
T2	p 117 153	people with diabetes , renal disease
T3	p 221 240	renal insufficiency
T4	p 286 308	nondiabetic population
T5	p 389 401	HOPE ( Heart
T6	p 496 577	9297 participants , including 3577 with diabetes and 1956 with microalbuminuria .
T7	p 607 959	7674 participants with albuminuria data at baseline and at follow-up . Inclusion criteria were known vascular disease or diabetes plus one other cardiovascular risk factor , exclusion criteria included heart failure or known impaired left ventricular function , dipstick-positive proteinuria ( > 1+ ) , and serum creatinine > 2.3 mg/dl ( 200 microM ) .
T8	p 1833 1850	diabetic people .
T9	i 462 470	ramipril
T10	i 485 492	placebo
T11	i 708 716	vascular
T12	i 728 741	diabetes plus
T13	i 772 778	factor
T14	i 1519 1527	Ramipril
T15	i 1851 1859	Ramipril
T16	o 358 369	proteinuria
T17	o 1007 1027	clinical proteinuria
T18	o 1304 1330	progression of albuminuria
T19	o 1348 1394	microalbuminuria or new clinical proteinuria )
T20	o 1446 1462	microalbuminuria
T21	o 1496 1518	clinical proteinuria .
T22	o 1540 1544	risk
T23	o 1553 1564	progression
T24	o 1790 1810	clinical proteinuria